Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity by Zampogna, E. et al.
Effectiveness of a Pulmonary Rehabilitation Program on Persistent
Asthma Stratified for Severity
Elisabetta Zampogna, Mara Paneroni, Francesca Cherubino, Patrizia Pignatti, Monica Rudi,
Giulia Casu, Michele Vitacca, Antonio Spanevello, and Dina Visca
BACKGROUND: Asthma is defined by airway inflammation associated with various respiratory
symptoms, and pharmacologic treatment is based on inhaled corticosteroids and bronchodilators.
Physical activity, educational training, nutritional support, and psychological counseling are con-
sidered part of non-pharmacologic treatment; however, studies so far have investigated the effect
of single non-pharmacologic treatment. There are few studies that demonstrate the effect of com-
prehensive pulmonary rehabilitation, but no clear data are available regarding factors that can
predict who could benefit the most. Our study aimed to assess the effect of a comprehensive 3-week
pulmonary rehabilitation program on exercise tolerance and to identify baseline subject characteristics
that may predict a better response to treatment. METHODS: This was a retrospective study. A team
planned a pulmonary rehabilitation program: educational support; endurance training; and optional
components, such as respiratory exercises and airway clearance techniques. The following data were
collected before and after pulmonary rehabilitation: subject characteristics, smoking history, asthma
severity, respiratory function and 6-min walk test (6MWT). RESULTS: We collected data on 515 sub-
jects (202 males 39.2%), age, mean  SD 63.9  10.4 y), with 413 (80.2%) having moderate-to-severe
disease; and 455 (88.4%) with stable respiratory symptoms 455 (88.35%). At baseline, the percentage of
predicted 6MWT in all subjects categorized by the Global Initiative for Asthma (GINA) steps was in the
normal range, except for the subjects at step 5, for which it was significantly lower (P  .01). All subjects
showed a significant improvement in exercise tolerance and oxygen saturation, together with a decrease
in baseline dyspnea, muscle fatigue, and heart rate after pulmonary rehabilitation. Improvement of
6MWT was statistically significant, irrespective of the GINA categorization. The variables related to the
improvement in 6MWT were age (P < .001), smoking habit (P  .034), and baseline 6MWT (P < .001).
CONCLUSIONS: Subjects with asthma at any GINA step seemed to benefit from a pulmonary reha-
bilitation program; analysis of our data highlighted that pulmonary rehabilitation was more beneficial
in younger subjects with a smoking history and worse baseline exercise tolerance. Key words: pulmonary
rehabilitation; exercise; asthma; 6MWT. [Respir Care 2019;64(12):1523–1530. © 2019 Daedalus Enterprises]
Introduction
The primary goals of asthma treatment include com-
plete symptom control, optimal management of limitations
in activities of daily living, and reduction of future exac-
erbation risk.1-4 Physical activity in patients with asthma is
limited by the fear of experiencing symptoms during ex-
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ercise,5-10 whereas their reduced capacity to manage daily
activities increases psychological distress, which affects
health status and quality of life.6,11 However, regular phys-
ical activity has been shown to reduce the risk of asthma
exacerbations.12
Supervised physical activity, as well as education pro-
grams,13 nutritional intervention, and psychological coun-
seling, are considered part of non-pharmacologic asthma
treatment.1,12 Results of a systematic review and meta-
analysis indicate that exercise training may reduce airway
hyperactivity and improve lung function and exercise ca-
pacity in subjects with asthma.14 It is worth noticing that,
even if most of the studies performed so far highlight that
exercise training is well tolerated and improves exertional
symptoms, anxiety, depression, cardiovascular fitness, and
health-related quality of life without affecting lung func-
tion; none of them have evaluated the influence of asthma
severity and age on outcomes.5-7,12,15
Although pulmonary rehabilitation has been demon-
strated to be effective, patients with asthma are not rou-
tinely referred for pulmonary rehabilitation,11 whereas there
are few studies that demonstrate the effect of a compre-
hensive pulmonary rehabilitation program,11,14,16,17 with
no clear data available regarding baseline factors that can
predict who could most benefit from pulmonary rehabili-
tation, especially when stratified by disease severity. When
considering the need to identify patients who can benefit
more from pulmonary rehabilitation, our study aimed to
assess the effect of a comprehensive 3-week pulmonary
rehabilitation program on exercise tolerance in subjects
with asthma as the primary outcome and to identify base-
line patient characteristics that may help to predict a better
response to pulmonary rehabilitation treatment.
Methods
Study Design and Participants
This retrospective study was conducted at Istituti Clinici
Scientifici Maugeri of Tradate (Varese), Italy. We ana-
lyzed all the medical records of consecutive patients with
asthma who followed a pulmonary rehabilitation program
from January 2007 to June 2017. Data were collected
through the hospital informatics system and completed
with medical records. The ethic committee of Istituti Cli-
nici Scientifici Maugeri approved the study protocol (2219,
July 19, 2018). Inclusion criteria were the following: pa-
tients  18 y, a diagnosis of asthma according to current
Global Initiative for Asthma (GINA) guidelines,1 pharma-
cologic treatment for asthma according to GINA guide-
lines over the previous 12 months, adherence of at least
80% to a standard rehabilitation program of 15 sessions,18
and the ability to perform and complete a 6-min walk test
(6MWT). Exclusion criteria were the following: the pres-
ence of concomitant diseases that could compromise the
pulmonary rehabilitation trial and a diagnosis of COPD.
Rehabilitative Intervention
The multidisciplinary team involved in the pulmonary re-
habilitation program included a pulmonologist (MV, AS, DV),
a nurse, a respiratory therapist (EZ, MP, MR), a psychologist,
and a dietitian. The 3-week rehabilitation trial included pre-
and post-rehabilitation evaluations of lung function static and
dynamic volumes according to the American Thoracic So-
ciety,19 performed by trained staff (EZ, MR, DV) in a lung
function laboratory with body plethysmograph (Masterlab
Body Jaeger, Würzburg, Germany), blood gas analysis
(automatic analyzer ABL 820 Radiometer Medical, Brøn-
shøj, Denmark), chest radiograph, 6MWT (according to
guidelines),20 and respiratory symptoms.21
The pulmonary rehabilitation program was tailored for
each subject’s needs and included endurance training; ed-
ucational support; and optional components, such as breath-
ing strategies (breathing retraining or pursed-lips breath-
ing in the case of dynamic hyperinflation or dyspnea, which
limits exercise capacity) and airway clearance techniques
(in the case of retained secretions). Moreover, according to
individual needs, psychological support, relaxation tech-
niques (when the psychological assessment found an emo-
tional impact of the illness, ie, anxiety state or depressive
symptom)12,22,23 and nutritional counseling (subjects who
QUICK LOOK
Current knowledge
Asthma is defined by airway inflammation associated
with respiratory symptoms, including wheezing, short-
ness of breath, chest tightness, and cough. Supervised
physical activity, as well as educational training, nutri-
tional intervention, and psychological counseling, are
considered part of non-pharmacologic asthma treatment.
Exercise training is well tolerated by patients with
asthma and improves exertional symptoms, cardiovas-
cular fitness, and health-related quality of life without
affecting lung function.
What this paper contributes to our knowledge
Subjects with asthma benefited from a pulmonary re-
habilitation program regardless of disease severity in
terms of respiratory symptoms, oxygenation at rest, and
exercise performance. The subjects who benefitted more
from pulmonary rehabilitation were younger and with a
worse lung-function impairment, lower baseline 6-min
walk distance, and a smoking history.
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were overweight or obese, or who had diabetes or other
metabolic issues) were added to provide a personalized
diet. Details of the pulmonary rehabilitation are shown in
the Table 1.
Outcome Measures
The following data were collected in an electronic da-
tabase: subject characteristics (age, sex); comorbidities;
smoking history and pack-years; asthma severity accord-
ing to GINA classification; respiratory function: FEV1 (L
and % of theoretical value) and FVC (L and % of theo-
retical value), FEV1/FVC, residual volume percentage, PaO2
(in mm Hg), PaCO2 (in mm Hg), pH, arterial oxygen satu-
ration (SaO2) before (T0) and after (T1) pulmonary reha-
bilitation program; and 6MWT: walk distance and per-
centage predicted, heart rate, SpO2) perceived dyspnea and
muscular fatigue before and after the test, measured with
the modified Borg scale at T0 and T1.
Statistical Analysis
All statistical analyses were conducted by using the ded-
icated software STATA 11.2 (StataCorp, College Station,
Texas). The before to after difference in effort tolerance
(6MWT) was evaluated by using the paired t test. To
predict factors related to effort tolerance improvement, a
single linear regression analysis was performed. The dif-
ference in meters between the final and initial 6MWT was
considered a dependent variable. All other anthropometric,
clinical, and functional collected measures were consid-
ered as independent variables. With regard to the severity
of the disease, we evaluated the different percentages of
the 6MWT predicted value among the 5 GINA steps at
baseline and after the rehabilitative treatment by using the
one-way analysis of variance test. P  .05 was considered
statistically significant.
Results
The flow chart of the study design is shown in Figure 1.
We collected data of 515 subjects with asthma who com-
pleted the program. The study population included 313 fe-
males and 202 males. Baseline demographics, anthropo-
metrics, and physiologic and clinical data of the subjects
are shown in Table 2. The cohort was mainly composed of
Table 1. Pulmonary Rehabilitation Details
Component Detail Session
Pulmonary rehabilitation components
Endurance training (cycle ergometer) 30 min (5 min warm-up, 20 min training and 5 min cool-down) at
constant load (starting from the 50–70% of theoretical watt
maximum, calculated with Luxon equation,* and adjusted on
subject’s tolerance†
15 Sessions, one time a day,
5 d/wk
Educational program Optimization of inhalation techniques 2 Individual sessions
Peak expiratory flow monitoring Individual daily session
Characteristics of asthma and the Asthma Action Plan 2 Face-to-face sessions
Lifestyle, physical activity, and maintenance programs 2 Group sessions
Optional components
Respiratory exercises 30 min 1 Session/d
Airways clearance techniques 30 min 1/2 Session/d
Psychological support relaxation technique from 30 to 60 mins 3 Sessions/wk
Progressive muscles relaxation, Jacobson method, 30 min 5 Sessions/wk
Nutritional counseling from 30 to 60 mins 2 Sessions
Each session and exercise was supervised by a respiratory therapist.
* From Reference 34.
† From Reference 35.
Patients with asthma
1,272




Referred to standard follow-up: 735
Did not complete PR: 20
Fig. 1. Flow chart. PR  pulmonary rehabilitation.
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women with asthma who were clinically stable and clas-
sified as GINA step 4. Among the study population, the
most common comorbidities were obesity (30%), bronchi-
ectasis (15.3%), type 2 diabetes (4%), and upper respira-
tory tract diseases (2.5%). Borg dyspnea and fatigue were
missing for 7.9% of the entire cohort. The sex distribution
in the different GINA steps is shown in Figure 2.
At baseline, the percentage of predicted 6MWT in all
GINA steps was in the normal range, except for the sub-
jects at step 5, for which it was significantly lower
(80.14%  20.30%, P  .01) (Fig. 3). Overall, the sub-
jects completed the 6MWT before and after the pulmonary
rehabilitation program. The pre-to-post change in 6MWT
is described in Table 3. All the subjects showed a signif-
icant improvement in exercise tolerance and oxygen sat-
uration after pulmonary rehabilitation, together with a de-
crease in baseline dyspnea and heart rate. The 6-min walk
distance increased by 39.62 m on average (95% CI
18 to 123 m).
With regard to the severity of the disease, a box plot of
percentages of the predicted value of 6MWT among the
5 GINA steps at baseline and the changes after the reha-
bilitative treatment are shown in Figure 2. Improvement of
6MWT was statistically significant, irrespective of the
GINA groups. The variables, according to the univariate
linear regression analysis (Table 4), significantly related to
the improvement in 6MWT were the following: age
(P  .001), smoking habit (P  .034), and baseline 6MWT
(P  .001). Younger subjects with a smoking habit and
lower effort tolerance at the beginning of the rehabilitative
intervention were the ones most likely to improve their
functional capacity after the rehabilitation program.
Discussion
Our retrospective study aimed to assess the effect of a
3-week pulmonary rehabilitation program on exercise tol-
erance in subjects with asthma at any stage of disease and
to identify baseline subject characteristics that may predict
a better response to treatment. Analysis of our data showed
a significant improvement in terms of exercise performance,
dyspnea, muscle fatigue, and oxygenation at rest in the
subjects with asthma, independent from disease severity,
which suggested that patients with asthma may also ben-
efit from a comprehensive pulmonary rehabilitation pro-
gram (including endurance training, respiratory exercises,
psychological support, and nutritional counseling). A
higher improvement in exercise tolerance was related to a
lower baseline 6-min walk distance, younger age, and the
presence of a smoking habit. Furthermore, to the best of
our knowledge, this was the first study with such a large
cohort of subjects with asthma.
In our study, the average baseline 6MWD was 460 m.
It is known that age, height, weight, and sex independently






Admission diagnosis, n (%)
Stable asthma 455 (88.35)
Exacerbation 60 (11.65)










Ophthalmologic and ORL 20 (3.88)
Upper gastrointestinal 35 (6.79)
Endocrine, metabolic 217 (42.13)
Other 29 (5.61)
Age
Entire cohort, mean  SD y 63.93  10.37






PFT, mean  SD
FEV1, L 1.88  0.68
FEV1, % 82.17  22.48
FVC, L 2.82  2.71
FVC, % 96.70  52.90
FEV1/FVC 0.67  12
RV, % 137.43  34.85
Blood gas analysis
PaO2, mm Hg 77.62  8.75
PaCO2, mm Hg 36.93  3.68
pH 7.43  0.03
SaO2, % 95.56  1.48
6MWT, mean  SD
Distance, m 459.92  94.10
Percentage 98.41  19.23
Resting heart rate, beats/min 77.94  11.41
Maximum heart rate, beats/min 112.67  15.50
Resting SpO2, % 94.97  1.78
Nadir SpO2, % 92.27  2.77
Resting Borg dyspnea, n 0.82  1.06
Borg dyspnea post 6MWT, n 3.28  1.94
Resting Borg fatigue, n 0.67  1.16
Borg fatigue post 6MWT, n 2.97  2.20
* Bronchiectasis, upper respiratory tract disease.
GINA  Global Initiative for Asthma
ORL  otorhinolaryngology
PFT  pulmonary function test
RV  residual volume
6MWT  6-min walk test
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Step 2 Step 3 Step 4
P = .72
Step 5
Fig. 3. Box plots of percentage of the 6-min walk test. A: Baseline. B: pre pulmonary rehabilitation-post pulmonary rehabilitation. Boxes
denote variation from minimum to maximum, interquartile range, and median of data.
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affect the 6MWT. The performance of our cohort was
below expected for a healthy population, even if the per-
centage of predicted results were within normal limits.24,25
These data might reflect the fact that patients with asthma
reduce their physical activity and exercise capacity be-
cause of the fear of experiencing symptoms during or after
exercise.5-7 Furthermore, we could not exclude the possi-
bility that 6MWT could be affected by body weight in
30% of the total study population, as documented in pre-
vious studies.26 In this study, an improvement in terms of
functional performance, dyspnea, and muscle fatigue was
obtained in all the subjects, independent from asthma se-
verity.
Our results were in line with other previous stud-
ies11,16,17 with fewer subjects. Many investigators re-
ported that exercise training is well tolerated by patients
with asthma and is able to improve symptoms, cardio-
vascular fitness, health-related quality of life, anxiety,
depression, pulmonary function, and the 6MWT, and to
reduce bronchial hyperresponsiveness and serum proin-
flammatory cytokines.5-7,11,16,17,27,28
Our subjects were mainly middle-age women with more
severe asthma, as previously reported.29 Interestingly, a
higher CI in effort tolerance was found in more severe
GINA groups (eg, GINA step 4); this might reflect the
increase in variability of functional impairment of patients
when severity of the disease increases. In this group, there
are probably subjects with a normal functional ability but
also subjects with walking disability due to dyspnea or
fatigue, whereas the majority of subjects with less severe
asthma had a functional ability close to normality. Again,
analysis of our data showed a significant reduction of func-
tional capacity in the subjects at GINA step 5, and a
6MWT  82% of predicted, which is usually considered
a threshold of normality.26 In our study, the baseline walk
distance increased by 40 m after pulmonary rehabilitation.
This result was similar to those reported in another study
that investigated subjects with asthma with different levels
of disease control.16 Better results are reported in the study
of Lingner et al,11 in which the walk distance increased by
60 m. When compared with our study, the different level
of improvement may be due to different subject charac-
teristics; our subjects were older, with more severe ob-
struction.
Our study showed an improvement in the resting Borg
dyspnea scale, resting heart rate, and resting oxygen
saturation as demonstration of significant improvement
in post-exercise dyspnea and muscle fatigue, although
an important increase in effort tolerance. This result
support the positive role of pulmonary rehabilitation in
patients with asthma. Interestingly, the strongest vari-
able to explain the improvement in exercise was the
baseline 6MWD. Age and smoking habit, although sig-
nificant, presented a lower R2, with less affect on the
outcome. These results confirmed that the rehabilitation
Table 3. Entire Cohort Pre-to-Post Pulmonary Rehabilitation Program Change in 6MWT
Parameter T0 T1 P
6MWD, m 459.99  94.10 499.61  89.99 .001
Resting Borg dyspnea, n 0.90  1.05 0.57  0.82 .001
Resting Borg fatigue, n 0.67  1.16 0.43  0.87 .001
Resting heart rate, beats/min 77.94  11.41 76.76  11.10 .01
Mean resting SpO2, % 94.97  1.78 95.46  1.64 .001
Borg dyspnea post 6MWT, n 3.28  1.94 2.63  1.75 .001
Borg fatigue post 6MWT, n 2.97  2.20 2.48  1.97 .001
Data are mean  SD.
6MWD  6-min walk distance
T0  before the pulmonary rehabilitation program
T1  after the pulmonary rehabilitation program




B 95% CI Standard Error R2 P
Pre-to-post change
6MWD, m
Baseline 6MWD, m 0.0160 0.200 to 0.120 0.020 0.11 .001
Age, y 0.747 1.123 to 0.370 0.191 0.02 .001
Smoking habit 4.659 0.357–8.96 2.190 0.01 .034
6MWD  6-min walk distance
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benefits were often more pronounced in patients who
were more disabled.
According to Demoly et al,30 50% of subjects with
asthma in 5 European countries, including Italy, reported
poor symptom control, thus additional studies are required
to better understand how to improve the role of non-phar-
macologic treatment, such as patient education and train-
ing. As part of the pulmonary rehabilitation program, pul-
monologists (MV, AS, DV) taught our subjects about
disease management and asthma action plans to improve
respiratory symptom control, according to our previous
experience, which we named “asthma school.”31 We do
not know how this educational program has influenced,
per se, the positive results. However, previous studies
showed that combining effective management of inhaled
medications and pulmonary rehabilitation elicit better re-
sults than either therapy or pulmonary rehabilitation
alone.32,33
Our study had some limitations. As with all retrospec-
tive studies, these were missing data (7.9% of the Borg
values, asthma control, drug history, quality of life and
subjective customer satisfaction), which led to a risk of
decreasing accuracy and a lack of important information.
Another limitation was that we were not able to extrapo-
late the single or synergic role of medication readjust-
ments and the rehabilitation program in our multidisci-
plinary program. However our data mirror real-life
conditions encountered by health-care services in selecting
patients who may benefit from pulmonary rehabilitation.
Conclusions
Our results showed that subjects with asthma at any
GINA step may benefit from a comprehensive pulmonary
rehabilitation program in terms of respiratory symptoms,
muscle fatigue, and oxygenation at rest and during exer-
cise. In addition, our data highlighted that the pulmonary
rehabilitation program was more beneficial in younger sub-
jects with smoking history and worse baseline effort tol-
erance. However, additional prospective studies are needed
to better define the characteristics of patients who may
benefit the most and to evaluate the effective role of each
component of a comprehensive pulmonary rehabilitation
to reach better disease control.
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